Press Release October 13, 2021New Data at ECTRIMS 2021 Highlight Biogen's Focus on Patient-Centered Outcomes and Improving the MS Patient Experience 0 0 Share
Press Release October 13, 2021New MS PATHS Data at ECTRIMS 2021 Confirm Biogen's Disease-Modifying Therapies Do Not Reduce Antibody Response to COVID-19 Vaccines in People with Multiple Sclerosis 0 0 Share
Company Ticker News October 8, 2021Could Biogen's Blockbuster Hopes for Alzheimer's Disease Drug Aduhelm Be Doomed? 0 0 Share
Company Ticker News October 7, 20213 Biotech Stocks That Could Make You Richer in October and Beyond 0 0 Share
Press Release October 4, 2021Sage Therapeutics and Biogen Announce Consistent Clinically Meaningful Data for Zuranolone Across the LANDSCAPE and NEST Clinical Development Programs Presented at the European College of Neuropsychopharmacology (ECNP) Congress 0 0 Share
